Your browser doesn't support javascript.
loading
Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer.
Haga, Yuya; Higashisaka, Kazuma; Yang, Lili; Sekine, Naoki; Lin, Ying; Tsujino, Hirofumi; Nagano, Kazuya; Tsutsumi, Yasuo.
Affiliation
  • Haga Y; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Higashisaka K; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Department of Legal Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. Electronic address: higas
  • Yang L; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Sekine N; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Lin Y; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tsujino H; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nagano K; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tsutsumi Y; Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan; Global Center for Medical Engineering and Informatics, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. Electronic address: ytsutsum
Biochem Biophys Res Commun ; 533(4): 672-678, 2020 12 17.
Article in En | MEDLINE | ID: mdl-33036754

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / Proto-Oncogene Proteins c-akt / TOR Serine-Threonine Kinases / Triple Negative Breast Neoplasms / Dasatinib / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2020 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Protein Kinase Inhibitors / Proto-Oncogene Proteins c-akt / TOR Serine-Threonine Kinases / Triple Negative Breast Neoplasms / Dasatinib / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2020 Type: Article Affiliation country: Japan